Global mRNA Vaccine And Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 933868 | Published Date: Apr 2024 | No. of Page: 109 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Infectious Disease
        1.2.3 Cancer
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global mRNA Vaccine And Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Research Institual
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global mRNA Vaccine And Therapeutics Market Perspective (2016-2027)
    2.2 mRNA Vaccine And Therapeutics Growth Trends by Regions
        2.2.1 mRNA Vaccine And Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 mRNA Vaccine And Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 mRNA Vaccine And Therapeutics Industry Dynamic
        2.3.1 mRNA Vaccine And Therapeutics Market Trends
        2.3.2 mRNA Vaccine And Therapeutics Market Drivers
        2.3.3 mRNA Vaccine And Therapeutics Market Challenges
        2.3.4 mRNA Vaccine And Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue
        3.1.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue
    3.4 Global mRNA Vaccine And Therapeutics Market Concentration Ratio
        3.4.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2020
    3.5 mRNA Vaccine And Therapeutics Key Players Head office and Area Served
    3.6 Key Players mRNA Vaccine And Therapeutics Product Solution and Service
    3.7 Date of Enter into mRNA Vaccine And Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Vaccine And Therapeutics Breakdown Data by Type
    4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2022-2027)

5 mRNA Vaccine And Therapeutics Breakdown Data by Application
    5.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America mRNA Vaccine And Therapeutics Market Size (2016-2027)
    6.2 North America mRNA Vaccine And Therapeutics Market Size by Type
        6.2.1 North America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
    6.3 North America mRNA Vaccine And Therapeutics Market Size by Application
        6.3.1 North America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
    6.4 North America mRNA Vaccine And Therapeutics Market Size by Country
        6.4.1 North America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe mRNA Vaccine And Therapeutics Market Size (2016-2027)
    7.2 Europe mRNA Vaccine And Therapeutics Market Size by Type
        7.2.1 Europe mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
    7.3 Europe mRNA Vaccine And Therapeutics Market Size by Application
        7.3.1 Europe mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
    7.4 Europe mRNA Vaccine And Therapeutics Market Size by Country
        7.4.1 Europe mRNA Vaccine And Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe mRNA Vaccine And Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type
        8.2.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application
        8.3.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region
        8.4.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America mRNA Vaccine And Therapeutics Market Size (2016-2027)
    9.2 Latin America mRNA Vaccine And Therapeutics Market Size by Type
        9.2.1 Latin America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America mRNA Vaccine And Therapeutics Market Size by Application
        9.3.1 Latin America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America mRNA Vaccine And Therapeutics Market Size by Country
        9.4.1 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type
        10.2.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application
        10.3.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country
        10.4.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Argos Therapeutics
        11.1.1 Argos Therapeutics Company Details
        11.1.2 Argos Therapeutics Business Overview
        11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction
        11.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.1.5 Argos Therapeutics Recent Development
    11.2 BioNTech
        11.2.1 BioNTech Company Details
        11.2.2 BioNTech Business Overview
        11.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction
        11.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.2.5 BioNTech Recent Development
    11.3 CureVac
        11.3.1 CureVac Company Details
        11.3.2 CureVac Business Overview
        11.3.3 CureVac mRNA Vaccine And Therapeutics Introduction
        11.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.3.5 CureVac Recent Development
    11.4 eTheRNA
        11.4.1 eTheRNA Company Details
        11.4.2 eTheRNA Business Overview
        11.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction
        11.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.4.5 eTheRNA Recent Development
    11.5 Ethris
        11.5.1 Ethris Company Details
        11.5.2 Ethris Business Overview
        11.5.3 Ethris mRNA Vaccine And Therapeutics Introduction
        11.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.5.5 Ethris Recent Development
    11.6 In-Cell-Art
        11.6.1 In-Cell-Art Company Details
        11.6.2 In-Cell-Art Business Overview
        11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction
        11.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.6.5 In-Cell-Art Recent Development
    11.7 Moderna Therapeutics
        11.7.1 Moderna Therapeutics Company Details
        11.7.2 Moderna Therapeutics Business Overview
        11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction
        11.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.7.5 Moderna Therapeutics Recent Development
    11.8 Sangamo Therapeutics
        11.8.1 Sangamo Therapeutics Company Details
        11.8.2 Sangamo Therapeutics Business Overview
        11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction
        11.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.8.5 Sangamo Therapeutics Recent Development
    11.9 Tiba Biotechnology
        11.9.1 Tiba Biotechnology Company Details
        11.9.2 Tiba Biotechnology Business Overview
        11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction
        11.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.9.5 Tiba Biotechnology Recent Development
    11.10 Translate Bio
        11.10.1 Translate Bio Company Details
        11.10.2 Translate Bio Business Overview
        11.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction
        11.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2016-2021)
        11.10.5 Translate Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Infectious Disease
    Table 3. Key Players of Cancer
    Table 4. Key Players of Others
    Table 5. Global mRNA Vaccine And Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global mRNA Vaccine And Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global mRNA Vaccine And Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global mRNA Vaccine And Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global mRNA Vaccine And Therapeutics Market Share by Regions (2022-2027)
    Table 11. mRNA Vaccine And Therapeutics Market Trends
    Table 12. mRNA Vaccine And Therapeutics Market Drivers
    Table 13. mRNA Vaccine And Therapeutics Market Challenges
    Table 14. mRNA Vaccine And Therapeutics Market Restraints
    Table 15. Global mRNA Vaccine And Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global mRNA Vaccine And Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2020)
    Table 18. Ranking of Global Top mRNA Vaccine And Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by mRNA Vaccine And Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players mRNA Vaccine And Therapeutics Product Solution and Service
    Table 22. Date of Enter into mRNA Vaccine And Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global mRNA Vaccine And Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Argos Therapeutics Company Details
    Table 63. Argos Therapeutics Business Overview
    Table 64. Argos Therapeutics mRNA Vaccine And Therapeutics Product
    Table 65. Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. Argos Therapeutics Recent Development
    Table 67. BioNTech Company Details
    Table 68. BioNTech Business Overview
    Table 69. BioNTech mRNA Vaccine And Therapeutics Product
    Table 70. BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. BioNTech Recent Development
    Table 72. CureVac Company Details
    Table 73. CureVac Business Overview
    Table 74. CureVac mRNA Vaccine And Therapeutics Product
    Table 75. CureVac Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. CureVac Recent Development
    Table 77. eTheRNA Company Details
    Table 78. eTheRNA Business Overview
    Table 79. eTheRNA mRNA Vaccine And Therapeutics Product
    Table 80. eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. eTheRNA Recent Development
    Table 82. Ethris Company Details
    Table 83. Ethris Business Overview
    Table 84. Ethris mRNA Vaccine And Therapeutics Product
    Table 85. Ethris Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Ethris Recent Development
    Table 87. In-Cell-Art Company Details
    Table 88. In-Cell-Art Business Overview
    Table 89. In-Cell-Art mRNA Vaccine And Therapeutics Product
    Table 90. In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. In-Cell-Art Recent Development
    Table 92. Moderna Therapeutics Company Details
    Table 93. Moderna Therapeutics Business Overview
    Table 94. Moderna Therapeutics mRNA Vaccine And Therapeutics Product
    Table 95. Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. Moderna Therapeutics Recent Development
    Table 97. Sangamo Therapeutics Company Details
    Table 98. Sangamo Therapeutics Business Overview
    Table 99. Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Sangamo Therapeutics Recent Development
    Table 101. Tiba Biotechnology Company Details
    Table 102. Tiba Biotechnology Business Overview
    Table 103. Tiba Biotechnology mRNA Vaccine And Therapeutics Product
    Table 104. Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Tiba Biotechnology Recent Development
    Table 106. Translate Bio Company Details
    Table 107. Translate Bio Business Overview
    Table 108. Translate Bio mRNA Vaccine And Therapeutics Product
    Table 109. Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. Translate Bio Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global mRNA Vaccine And Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Infectious Disease Features
    Figure 3. Cancer Features
    Figure 4. Others Features
    Figure 5. Global mRNA Vaccine And Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Research Institual Case Studies
    Figure 8. mRNA Vaccine And Therapeutics Report Years Considered
    Figure 9. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global mRNA Vaccine And Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 12. Global mRNA Vaccine And Therapeutics Market Share by Regions (2022-2027)
    Figure 13. Global mRNA Vaccine And Therapeutics Market Share by Players in 2020
    Figure 14. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2020
    Figure 16. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 17. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 18. North America mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
    Figure 20. North America mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
    Figure 21. North America mRNA Vaccine And Therapeutics Market Share by Country (2016-2027)
    Figure 22. United States mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
    Figure 26. Europe mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
    Figure 27. Europe mRNA Vaccine And Therapeutics Market Share by Country (2016-2027)
    Figure 28. Germany mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Region (2016-2027)
    Figure 38. China mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
    Figure 46. Latin America mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
    Figure 47. Latin America mRNA Vaccine And Therapeutics Market Share by Country (2016-2027)
    Figure 48. Mexico mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Country (2016-2027)
    Figure 54. Turkey mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 58. BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 59. CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 60. eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 61. Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 62. In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 63. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 64. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 65. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 66. Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Argos Therapeutics
BioNTech
CureVac
eTheRNA
Ethris
In-Cell-Art
Moderna Therapeutics
Sangamo Therapeutics
Tiba Biotechnology
Translate Bio
Frequently Asked Questions
mRNA Vaccine And Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
mRNA Vaccine And Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
mRNA Vaccine And Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bicycle Peripheral

Bicycle peripheral refers to the constituents used for riding a bicycle. It mainly includes cycli ... Read More

Avian Flu Treatment

Avian flu, which is generally known as bird flu, is an infectious viral disease commonly found in ... Read More